Results 41 to 50 of about 12,760 (216)
Antimicrobial photodynamic therapy in Candida spp. biofilms: In vitro and in vivo protocols
This review addresses the critical challenges in translating in vitro antimicrobial photodynamic therapy protocols to in vivo models, with a particular focus on the hurdles of standardization. The vast diversity in photosensitizers and light parameters across different target cells and models requires a rigorous optimization process.
Lívia Mara Alves Figueiredo‐Godoi +2 more
wiley +1 more source
The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis
The article tells about the key problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Candida albicans causes 75--80% of candidiasis cases.
V. N. Serov +3 more
doaj +1 more source
Comparison of vaginal ointment of honey and clotrimazole for treatment of vulvovaginal candidiasis: A random clinical trial [PDF]
BACKGROUND AND OBJECTIVE: Vulvovaginal candidiasis (VVC) is the most prevalent vaginitis in women, accounting for 10 million medical referrals a year. Vaginal clotrimazole is a drug of choice for VVC treatment. However, increased drug resistance to this
Banaeian-Borujeni, Shayesteh +4 more
core +1 more source
Achillea millefolium Linn., commonly known as yarrow, is an extraordinary medicinal plant. A. millefolium has broad therapeutic potential due to its phytochemistry and essential oil composition. It possesses pharmacological properties, including antidiabetic, antioxidant, anti‐inflammatory, liver‐protective, antimicrobial, and gastroprotective effects,
Tooba Majeed +14 more
wiley +1 more source
Effective treatment for vulvovaginal candidiasis: case reports [PDF]
Effective treatment for vulvovaginal candidiasis: case reports A.L. Tikhomirov1, S.I. Sarsaniya2 1A.I. Evdokimov Moscow University of Medicine and Dentistry, Moscow, Russian Federation 2LLC “S-Mariya”, Moscow, Russian Federation Treatment ...
Tikhomirov A.L., Sarsaniya S.I.
doaj
Efficacy of metronidazole and miconazole vaginal co-formulation for bacterial vaginosis and vulvovaginal candidiasis [PDF]
E.A. Markova Pirogov Russian National Research Medical University, Moscow, Russian Federation Recurrent vulvovaginal infections being an epidemiological and clinical issue also have social and psychological implications.
E.A. Markova
doaj
Preserving reproductive health before the first pregnancy
Research objective: to evaluate the effectiveness of drugs based on decamethoxine for the treatment of inflammatory diseases of genital organs in adolescent girls entering reproductive age. Materials and methods. The study included 96 patients aged 17–19
О.V. Kravchenko
doaj +1 more source
ABSTRACT Objective To estimate miscarriage risk following gestational antimicrobial exposure while addressing biases that have affected previous studies. Design Population‐based cohort study. Setting Linkage of four nationwide registries: Medical Birth Registry of Norway (MBRN), Norwegian Prescribed Drug Registry (NorPD), Norwegian Patient Registry ...
Thomas Boissiere‐O'Neill +3 more
wiley +1 more source
Sertaconazole in the treatment of vulvovaginal candidiasis
Vulvovaginal candidiasis today is one of the most pressing problems in the field of women’s health. However, the prevalence of Candida with formed drug resistance to fluconazole significantly complicates the treatment of this disease.
Z. N. Efendieva
doaj +1 more source
Probiotic supplementation during pregnancy shows a modest, non‐robust increase in Group B Streptococcus decolonization, with no consistent benefit for bacterial vaginosis or vulvovaginal candidiasis. Probiotics may serve as a non‐antibiotic adjunct, but standardized regimens and ecological diagnostic frameworks are required.
Zimo Liu +3 more
wiley +1 more source

